Researchers at the Leibniz Institute of Polymer Research Dresden have developed a data-driven approach using engineered biomaterials to control how pancreatic cancer cells transition between different states in laboratory organoid models. The breakthrough, published in Advanced Materials, addresses a critical gap in cancer research: traditional culture methods fail to capture the dynamic behavior of tumor cells, which can rapidly shift in response to treatment or environmental pressure.
Using computational analysis and machine learning, the team identified specific combinations of biomaterial stiffness, porosity, and surface chemistry that drive particular cellular transitions. These engineered microenvironments successfully induced changes in cell adhesion, migration capacity, and drug resistance patterns—key factors that complicate pancreatic cancer treatment. The findings could reshape our understanding of tumor plasticity and inform development of more effective therapeutic strategies for one of oncology’s most challenging malignancies.
Read the full article on GMJ Newsroom.
Was this article helpful?
